Patel, V.; Li, Y.N.; Benhamou, L.-R.E.; Park, H.G.; Raleigh, M.; Brenna, J.T.; Powers, J.T.
Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a MYCN-Driven Neuroblastoma Model. Cancers 2025, 17, 362.
https://doi.org/10.3390/cancers17030362
AMA Style
Patel V, Li YN, Benhamou L-RE, Park HG, Raleigh M, Brenna JT, Powers JT.
Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a MYCN-Driven Neuroblastoma Model. Cancers. 2025; 17(3):362.
https://doi.org/10.3390/cancers17030362
Chicago/Turabian Style
Patel, Vishwa, Yan Ning Li, Lorraine-Rana E. Benhamou, Hui Gyu Park, Mariya Raleigh, J. Thomas Brenna, and John T. Powers.
2025. "Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a MYCN-Driven Neuroblastoma Model" Cancers 17, no. 3: 362.
https://doi.org/10.3390/cancers17030362
APA Style
Patel, V., Li, Y. N., Benhamou, L.-R. E., Park, H. G., Raleigh, M., Brenna, J. T., & Powers, J. T.
(2025). Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a MYCN-Driven Neuroblastoma Model. Cancers, 17(3), 362.
https://doi.org/10.3390/cancers17030362
